Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

ECX vs LICN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ECX Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 8–1 Matrix Metrics)

ECX Overall Winner 6-Pillar Tally: ECX 6 – 0 LICN Matrix Metrics: ECX 8 – 1 LICN

As of Nov 19, 2026, ECARX Holdings Inc. Class A (ECX) is the stronger overall head-to-head candidate over Lichen China Limited Class A (LICN) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ECX carries a Unified Composite Score of 52.4/100 (HOLD) at $0.69 (12.1x Forward P/E, -4.6% operating margin), whereas LICN carries 45.6/100 (HOLD) at $0.01 (N/M Forward P/E, -87.1% operating margin).

  • Technical & Structure Timing Caution: ECX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.6); meanwhile LICN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 15.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ECX vs LICN
ECX NASDAQ Head-to-Head Winner
ECARX Holdings Inc. Class A Ordinary shares
Services-Computer Integrated Systems Design
$0.69
-9.78% 1D
Market Cap $300.6M
TTM Revenue $902M
Forward P/E 12.1x
Beta / 30D Vol 0.44β · 122% Vol
Unified Composite Score
52.4 / 100 HOLD
Tech 50.0 Fund 53.0 Flow 50.0 Mom 68.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -10.4%), weak momentum, RSI 39
RSI-14: 38.6 · SMA20: $0.81 · SMA50: $0.90
LICN NASDAQ
Lichen China Limited Class A Ordinary Shares
Services-Management Consulting Services
$0.01
-7.74% 1D
Market Cap $524,315
TTM Revenue $21M
Forward P/E N/M
Beta / 30D Vol 1.11β · 330% Vol
Unified Composite Score
45.6 / 100 HOLD
Tech 45.0 Fund 45.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -29.2%), weak momentum, RSI 15
RSI-14: 15.2 · SMA20: $0.43 · SMA50: $0.76

6-Pillar Scorecard Institutional Category Breakdown (ECX 6 – 0 LICN)

Columns: Metric · ECX · LICN
1. Valuation Multiples ECX
Forward P/E 12.1x N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 0.8x N/M
2. Growth & Scale ECX
Revenue Growth (YoY) +9.5% -28.0%
Earnings Growth (YoY) +0.0% -51.3%
TTM Revenue (USD) $902M $21M
Market Cap $300.6M $524,315
3. Profitability & Quality ECX
Gross Margin 15.3% 31.3%
Operating Margin -4.6% -87.1%
Net Profit Margin -7.4% -117.7%
Return on Equity (ROE) -2237.6% -38.6%
4. Balance Sheet & Cash Flow ECX
Cash Generation (TTM) -$22M EBITDA -$17M EBITDA
Cash Flow Margin -2.4% EBITDA Mgn -80.5% EBITDA Mgn
Net Cash / Leverage $466M Net Debt $3.73 Book/Sh · -38.6% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ECX
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat ECX
OpEx & R&D Intensity 19.9% of Rev ($180M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Auto Parts Operator Specialty Business Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ECX (8) vs LICN (1)
Institutional Metric ECX LICN Criterion Row Edge
Market Capitalization
Scale
$300.6M $524,315 Larger Scale ECX
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
12.1x N/M Lower Multiple ECX
Revenue Growth (YoY)
Growth
+9.5% -28.0% Higher Growth ECX
Operating Margin (TTM)
Profitability
-4.6% -87.1% Higher Margin ECX
Net Profit Margin
Profitability
-7.4% -117.7% Higher Margin ECX
Return on Equity (ROE)
Capital Efficiency
-2237.6% -38.6% Higher ROE LICN
52-Week Range Position
Momentum
1% ($1–$2) 0% ($0–$9) Stronger Trend ECX
Beta / 30D Volatility
Risk Regime
0.44β · 122% Vol 1.11β · 330% Vol Lower Realized Risk ECX
Unified Institutional Score
Composite Signal
52.4 / 100 (HOLD) 45.6 / 100 (HOLD) Higher Composite ECX
Trailing 12M Revenue (USD)
Operating Scale
$902M $21M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
15.3% 31.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.8x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$22M EBITDA ($466M Net Debt) -$17M EBITDA ($3.73 Book/Sh · -38.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ECX +75.71 pp
ECX: -22.63% · LICN: -98.34%
3M Horizon ECX +62.18 pp
ECX: -36.68% · LICN: -98.86%
6M Horizon ECX +66.7 pp
ECX: -31.66% · LICN: -98.36%
1Y Horizon ECX +38.99 pp
ECX: -60.56% · LICN: -99.55%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ECX vs LICN. Trailing 12-month operating profitability (ECX -4.6% vs LICN -87.1%) and valuation multiples (ECX 12.1x vs LICN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

ECX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$902M
Gross Margin15.3%
Op. Margin-4.6%
ROE / Fwd P/E-2237.6% · 12.1x
LICN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$21M
Gross Margin31.3%
Op. Margin-87.1%
ROE / Fwd P/E-38.6% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ECX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ECX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LICN BREAKDOWN
108d in phase · OBV DISTRIBUTION
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact LICN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ECX Moat Profile Cyclical / Execution-Driven Positioning
Auto Parts Operator
Competes within the Auto Parts value chain with $300.6M market capitalization and -4.6% operating margin.
OpEx & R&D Reinvestment 19.9% of Rev ($180M)
90D Engineering Disclosures 0 Published
LICN Moat Profile Cyclical / Execution-Driven Positioning
Specialty Business Services Operator
Competes within the Specialty Business Services value chain with $524,315 market capitalization and -87.1% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ ECX vs LICN Key Questions & Quantitative Answers

As of Nov 19, 2026, ECARX Holdings Inc. Class A (ECX) is the stronger overall head-to-head candidate over Lichen China Limited Class A (LICN) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ECX carries a Unified Composite Score of 52.4/100 (HOLD) at $0.69 (12.1x Forward P/E, -4.6% operating margin), whereas LICN carries 45.6/100 (HOLD) at $0.01 (N/M Forward P/E, -87.1% operating margin). Technical & Structure Timing Caution: ECX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.6); meanwhile LICN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 15.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ECX leads the Growth & Scale pillar: ECX posts +9.5% YoY revenue growth and +0.0% YoY earnings growth on $902M TTM revenue (15.3% gross margin, -4.6% operating margin), compared with LICN at -28.0% YoY revenue growth and -51.3% YoY earnings growth on $21M TTM revenue (31.3% gross margin, -87.1% operating margin). On trailing 12-month operating scale, ECX generates $902M in USD-normalized revenue versus $21M for LICN. In operating R&D and SG&A reinvestment, ECX deploys 19.9% of Rev ($180M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for LICN.

ECX screens cheaper on headline valuation multiples. ECX trades at 12.1x Forward P/E, N/M Trailing P/E, N/M PEG, and 0.8x EV/Revenue (-2.4% EBITDA margin), whereas LICN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (-80.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ECX (-2237.6% ROE) versus LICN (-38.6% ROE) capital efficiency.

In options market volatility and institutional positioning, ECX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.44β · 122% Vol realized risk). By comparison, LICN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.11β · 330% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.